How Racism Is Shaping the Coronavirus Pandemic
By Isaac Chotiner,
The New Yorker
| 05. 07. 2020
The historian Evelynn Hammonds talks about how false theories of “innate difference and deficit in black bodies” have shaped American responses to disease, from yellow fever to syphilis to COVID-19.
Evelynn Hammonds, who chairs Harvard’s department of the history of science, has spent her career studying the intersection of race and disease. She wrote a history of New York City’s attempt, a century ago, to control diphtheria, and is currently at work on a book of essays on the history of race, from Jefferson to genomics. Hammonds’s area of expertise is especially relevant today: while the data is incomplete, at this point in time, African-Americans represent nearly a third of U.S. deaths from the coronavirus pandemic and thirty per cent of covid-19 cases, despite making up only about thirteen per cent of the population. Hammonds noted recently, “This new development of what has happened with the pandemic with respect to African-American communities” is “perhaps an old development.”
I spoke by phone with Hammonds, who is currently hosting a series of Webinars with academics and experts at Harvard on African-Americans and epidemics in American history, from the eighteenth century to the present day. As she stated in one of the sessions, “I can’t imagine saying that we have to...
Related Articles
By Katie Palmer and Usha Lee McFarling, Stat | 09.03.2024
Photo by Hush Naidoo Jade Photography on Unsplash
Pediatrician Alexandra Epee-Bounya had had enough. In her 20 years caring for children in Boston, she had seen hundreds of kids with suspected urinary tract infections. Each time, she’d turn to a...
By Emily R. Klancher Merchant, Los Angeles Review of Books | 08.22.2024
IN THE Operation Varsity Blues scandal of 2019, 50 wealthy parents were charged with trying to get their children into elite universities through fraudulent means. The story dramatically demonstrated the lengths to which some parents will go to ensure their...
By Julia Brown, The Conversation | 08.16.2024
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and...
By Antonio Regalado, MIT Technology Review | 08.22.2024
In 2016, I attended a large meeting of journalists in Washington, DC. The keynote speaker was Jennifer Doudna, who just a few years before had co-invented CRISPR, a revolutionary method of changing genes that was sweeping across biology labs because...